IDEXX

(0)
Follow
Something About Company

10,000 people, one global focus – enhancing the health and well-being of pets, people, and livestock

We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.

Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.

We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.

Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.

0 Review

Rate This Company ( No reviews yet )

Work/Life Balance
Comp & Benefits
Senior Management
Culture & Value

Contact Us

https://cyberdefenseprofessionals.com/wp-content/themes/noo-jobmonster/framework/functions/noo-captcha.php?code=6a4bb

12th Anniversary Top InfoSec Innovator & Black Unicorn Awards for 2024 remain open for late entries! Winners Announced October 31, 2024

X